The collaboration will focus on preventive solutions, workshops, and public awareness. King Faisal Specialist Hospital and ...

Not available at this time. 1515 Aquarena Springs Drive, Ste. 105, San Marcos ...

In 2024, the FDA approved 19 biosimilars across various therapeutic areas, including the first biosimilars for ustekinumab ...

Ocugen, Inc. ("Ocugen" or the "Company") (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and ...

Ozempic has made headlines as a go-to medication for managing diabetes and aiding weight loss, but its popularity comes with ...

Susan Weiner, MS, RDN, CDN, CDCES, FACES, talks with Brenda Jagatic, BScN, RN, CDCES, about the prevalence of erectile ...

The Alberta Association of Optometrists is urging residents to contact their MLAs after Alberta Health announced changes to ...

Regardless of age at diagnosis or duration of disease, patients with diabetes who underwent intensive glucose lowering had lower risk for vascular events and death, according to a post hoc analysis ...

Barclays PLC increased its holdings in Kodiak Sciences Inc. (NASDAQ:KOD – Free Report) by 65.5% in the 3rd quarter, according ...

Kodiak Sciences Inc. (NASDAQ:KOD – Get Free Report) was the target of a large growth in short interest during the month of December. As of December 31st, there was short interest totalling 1,460,000 ...